Granahan Investment Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,063,486
Closed -$9.26M 202
2021
Q3
$9.26M Sell
1,063,486
-25,922
-2% -$236K 0.18% 119
2021
Q2
$11.1M Buy
1,089,408
+125,614
+13% +$1.33M 0.21% 108
2021
Q1
$11.5M Buy
963,794
+323,313
+50% +$3.67M 0.24% 80
2020
Q4
$5.82M Buy
640,481
+329,341
+106% +$2.55M 0.13% 121
2020
Q3
$1.9M Buy
311,140
+10,802
+4% +$82.4K 0.06% 157
2020
Q2
$2.67M Buy
300,338
+66,414
+28% +$573K 0.1% 140
2020
Q1
$1.7M Buy
+233,924
New +$1.73M 0.09% 144

Other funds holding NPTN

Granahan Investment Management's NPTN Position: Q4 2021 in Review

Granahan Investment Management sold out of NEOPHOTONICS CORP (NPTN) in Q4 2021, closing a stake of 1,063,486 shares — an estimated $9.26M sold.

Granahan Investment Management first reported a position in NPTN in Q1 2020 and held it in 7 quarters. The position peaked at $11.5M in Q1 2021. 145 funds tracked by Wall St. Rank hold NPTN as of Q4 2021.

  • Granahan Investment Management reported no remaining NEOPHOTONICS CORP position as of Q4 2021 after selling out during the quarter.
  • Granahan Investment Management sold 1,063,486 NEOPHOTONICS CORP shares in Q4 2021, an estimated $9.26M.
  • Granahan Investment Management first reported a position in NEOPHOTONICS CORP in Q1 2020 and held it in 7 quarters.
  • Granahan Investment Management's NEOPHOTONICS CORP position peaked at $11.5M in Q1 2021.
  • 145 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2021.

Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.